Efficacy and Prognosis of Auxiliary Liver Transplantation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorZhi-Jun Zhu
About this trial
The objective of this observational study is to systematically compare the efficacy and patient prognosis between auxiliary liver transplantation and living donor liver transplantation, and to explore the postoperative recovery, survival rate, rejection, postoperative complications, and long-term prognosis of patients undergoing auxiliary liver transplantation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who underwent auxiliary liver transplantation or living donor liver transplantation (LDLT).
Patients with complete medical records and follow-up data.
Disqualifiers
Patients who underwent retransplantation.
Patients who underwent other organ transplantation (or multiorgan transplantation).
Patients with severe missing postoperative follow-up data or loss to follow-up.
Trial population
Patients who were treated at the Liver Transplantation Center of Beijing Friendship Hospital, Capital Medical University between December 2025 and December 2028, and who underwent either auxiliary liver transplantation (study group) or conventional liver transplantation (control group).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 2 trial groupsGroup A: auxiliary liver transplantation
Group B: living donor liver transplantation
Trial outcomes
Primary outcomes
1
Overall survival
Time frame
Within one year after liver transplantationSecondary outcomes
1
Complications
Rejection, vascular, biliary and other related complications
Time frame
Within one year after liver transplantation2
changes in peripheral blood lymphocytes
Peripheral blood lymphocytes during the early post-transplant period were compared between the auxiliary and living donor liver transplantation groups to identify differences.
Time frame
within 3 months after liver transplantationLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zhi-Jun Zhu
Lead sponsor
Beijing Friendship Hospital
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: